In Stock, Ready to Ship!
$150.00
99% Pure | USA Made | Multi DoseSLU-PP-332 (Sloop Peptide) is a research peptide studied for its role in beta-3 adrenergic receptor signaling and downstream metabolic activation pathways. It’s commonly explored in models focused on energy utilization, fat-mobilization mechanisms, and thermogenic regulation. For research use only.
Key research highlights:
Beta-3 adrenergic activation: investigated for stimulating fat-cell signaling and metabolic output.
Thermogenesis pathways: studied for effects on heat-generation and energy-expenditure models.
Fat mobilization research: explored for encouraging lipolysis and adipose-tissue turnover.
Mitochondrial/energy utilization: examined in metabolic resilience and ATP-efficiency contexts.
Appetite & weight-stability models: often included in post-GLP research protocols.
Purity-driven consistency: 99%+ purity with third-party testing for reproducible study results.
Peptides are not ready to use. Must purchase BAC water for reconstitution.
Promotes selective apoptosis in β-galactosidase–positive cells, ideal for assays of senescence removal.
Modulates SIRT1 and FOXO signaling in aging models, enabling targeted investigation of pro-longevity mechanisms.
Enhances function and proliferation of endothelial and mesenchymal stem cells in vitro.
Uniform 10 mg capsules streamline rodent gavage and dietary admixture studies—no micro-weighing.
Capsules remain fully active for up to 12 months at room temperature, simplifying storage and planning.
Contains only microcrystalline cellulose, ensuring clean assay backgrounds and straightforward data interpretation.
SLU-PP-332, also known as SLOOP Peptide, is a synthetic research peptide studied for its regulatory role in cellular metabolism, mitochondrial function, and cognitive processes. It belongs to a class of molecules thought to activate PGC-1α, the master controller of mitochondrial biogenesis, making it of interest in aging, neurodegeneration, and energy-related research models.
Real Peptides delivers SLU-PP-332 at 99% purity, manufactured in the USA, with transparency and quality assurance for researchers. We offer this emerging peptide to support scientific exploration into how energy, brain health, and metabolism interact at the cellular level. Every batch is produced in ISO-certified labs with third-party purity testing. As always, this product is for research use only.
Unlike other peptides that work on hormone pathways, SLU-PP-332 operates primarily at the cellular level. It mimics physical activity effects at the molecular scale, showing promise in research exploring enhanced mitochondrial function, improved energy expenditure, and neuroprotection without traditional exercise stimuli. Its potential dual action on metabolism and cognition makes it a unique asset in peptide research.
To clear senescent cells, probe longevity pathways, and study stem-cell rejuvenation in vitro and in vivo.
Each oral capsule contains exactly 250mcg of SLU-PP-332 peptide.
Yes—empty the capsule into buffer or media. The powder dissolves rapidly for accurate dosing.
Common protocols use 1–5 mg/kg via oral gavage, adjusted per study design.
Researchers often employ 1–10 µM final concentration to assess senolytic activity.
Store at room temperature (15–25 °C) in a dry place; capsules retain full activity for 12 months.
Capsules ensure uniform 150mcg doses, eliminate weighing errors, and reduce contamination risk.
Only microcrystalline cellulose is used, minimizing assay interference.
The active peptide is HPLC-verified to ≥ 99% purity; for cell culture, solutions can be filtered if needed.
Real Peptides offers SLU-PP-332 250mcg capsules (100 count), USA-manufactured, ≥ 99% purity—strictly for research use only.
It is being explored in nootropic research models, particularly those involving mitochondrial support and brain performance.
SLU-PP-332 is a research-use-only peptide and has not been evaluated for safety or efficacy in humans. Therefore, no officially documented side effects exist. However, based on its mechanism — particularly its activation of PGC-1α and mitochondrial biogenesis — potential side effects in theoretical or preclinical contexts may include:
⚠️ SLU-PP-332 is intended strictly for laboratory research. It is not approved for human consumption or therapeutic use. All observations are hypothetical and based on preclinical research.
Research suggests SLU-PP-332 may activate AMPK pathways, mimicking exercise effects in cellular models.
It’s an abbreviation used in early-stage studies. “SLU” refers to its development origin, and “PP” denotes “peptide platform.”
Don't hestitate to contact us
End of Content.
